Evgen Pharma (EVG)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 0.80p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.05
  • 52 Week Low: 0.75
  • Currency: UK Pounds
  • Shares Issued: 427.35m
  • Volume: 0
  • Market Cap: £3.42m
  • RiskGrade: 304

Latest Deals

Traded Action Notifier PriceAmountValue
05-Apr-24 Buy Susan (Sue) Foden 1.00p 600,000 £6,000.00
05-Apr-24 Buy Toni Hänninen 1.00p 1,000,000 £10,000.00
05-Apr-24 Placing Huw Jones 1.00p 3,000,000 £30,000.00
05-Apr-24 Buy Huw Jones 1.44p 122,293 £1,761.02

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
05-Apr-24 Placing Huw Jones 1.00p 3,000,000 £30,000.00
05-Apr-24 Buy Toni Hänninen 1.00p 1,000,000 £10,000.00
05-Apr-24 Buy Susan (Sue) Foden 1.00p 600,000 £6,000.00
05-Apr-24 Buy Huw Jones 1.44p 122,293 £1,761.02

Director Shareholdings

Notifier Holding Value*
Huw Jones 3,184,793 £25,478
Toni Hänninen 1,000,000 £8,000
Susan (Sue) Foden 725,000 £5,800

Major Shareholders

Notifier** Holding Value*
James Robert Kight 33,100,000 £264,800
Rathbones Investment Management Ltd 25,789,246 £206,314
Octopus Investments Nominees Limited 21,875,000 £175,000
Octopus Investments Nominees Limited 21,875,000 £175,000
Vulpes Investment Management Pte Ltd 20,554,191 £164,434
First Equity Limited 20,000,000 £160,000
InterTrader Limited 16,560,033 £132,480
North West Fund (Biomedical) LP 16,186,446 £129,492
Seneca Partners Limited 14,932,071 £119,457
Richard Griffiths and family 14,408,000 £115,264
AXA Framlington Investment Management Limited 13,399,724 £107,198
Chelverton Asset Management 12,500,000 £100,000
RAB Capital 8,750,000 £70,000
David and Monique Newlands 8,314,815 £66,518
Newlands Capital 8,314,815 £66,518
Ali Mortazavi 3,400,000 £27,200
PARTNERS INVESTMENT COMPANY LLP 3,114,089 £24,913
Sarum Investment SICAV Plc 3,005,053 £24,040
Letzone Limited 2,664,000 £21,312
Beaufort Securities Limited 2,457,568 £19,660
South Yorkshire Investment Capital Fund LP 1,394,550 £11,156

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Evgen Pharma Market Data

Currency UK Pounds
Share Price 0.80p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.05
52 Week Low 0.75
Volume 0
Shares Issued 427.35m
Market Cap £3.42m
RiskGrade 304

Evgen Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.18% above the market average19.18% above the market average19.18% above the market average19.18% above the market average19.18% above the market average
84.91% above the sector average84.91% above the sector average84.91% above the sector average84.91% above the sector average84.91% above the sector average
Price Trend
93.46% below the market average93.46% below the market average93.46% below the market average93.46% below the market average93.46% below the market average
75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average75.44% below the sector average
Income Not Available
Growth Not Available

Evgen Pharma Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Evgen Pharma Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page